Added pain medicine for women having minimally invasive hysterectomy
Treatments studied
Part of Pain clinical trials.
This study tests whether adding suzetrigine to standard pain relief improves recovery after minimally invasive hysterectomy. Suzetrigine is a new type of painkiller that may reduce the need for opioids.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for a laparoscopic or robotic hysterectomy.
- You are in generally good health (classified as ASA I-III).
- You do not have chronic pain or take opioids regularly.
- You are not pregnant and do not have severe liver or kidney problems.
- You have no allergies to the study medications and can report your pain levels.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new non-opioid pain medicine called suzetrigine for pain after certain types of pelvic surgery. If it works, it might help you recover with fewer side effects than opioids.
This study tests a new non-opioid pain medicine called suzetrigine to see if it can control pain after vaginal pelvic surgery while reducing the need for opioid painkillers. If you are having this type of surgery soon, this trial might offer you an alternative for pain management.
This study tests a non-opioid pain medicine called suzetrigine (also known as Journavx) to see how well it controls pain after lower back surgery. It might be a good option if you're having lumbar fusion surgery and want to avoid the side effects of opioid painkillers.
This study tests a new pain medicine, suzetrigine, to see if it can reduce the need for opioids after a tonsillectomy or similar throat surgery. It aims to provide effective pain control with fewer opioid-related risks.
This study tests a new non-opioid pain medicine called suzetrigine to see how well it controls pain after ankle replacement surgery. The goal is to manage pain with fewer opioid-related side effects.
This study tests a new non-opioid pain medicine called suzetrigine to help women recover from C-section without relying on opioids. If you're having a C-section and want to manage pain during recovery with a non-opioid option, this trial may be a good fit.
Hear when a new Postoperative Pain trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.